A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.

Saved in:
Bibliographic Details
Title: A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.
Authors: Hashimoto T; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Medicine, Division of Medical Oncology, Showa University School of Medicine, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Yonemaru J; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Naka T; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Nagashima K; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Machida E; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yatabe Y; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan., Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan., Takashima A; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Sekine S; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. ssekine@ncc.go.jp.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan. ssekine@ncc.go.jp.
Source: British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (7), pp. 1176-1183. Date of Electronic Publication: 2023 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-023-02382-z